Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Delcath Systems, Inc.
Delcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Colorectal Cancer
December 02, 2024
From
Delcath Systems, Inc.
Via
Business Wire
Tickers
DCTH
Delcath Systems Reports Third Quarter 2024 Results and Business Highlights
November 08, 2024
From
Delcath Systems, Inc.
Via
Business Wire
Tickers
DCTH
Delcath Systems to Participate in Upcoming Investor Conferences
November 01, 2024
From
Delcath Systems, Inc.
Via
Business Wire
Tickers
DCTH
Delcath Systems to Host Third Quarter 2024 Earnings Call
October 25, 2024
From
Delcath Systems, Inc.
Via
Business Wire
Tickers
DCTH
Delcath Systems Announces Preliminary Third Quarter 2024 Revenue Results
October 17, 2024
From
Delcath Systems, Inc.
Via
Business Wire
Tickers
DCTH
Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 20, 2024
From
Delcath Systems, Inc.
Via
Business Wire
Tickers
DCTH
Delcath Systems Announces New Data Presented at ESMO 2024 Demonstrating Efficacy of HEPZATO KIT™ in Metastatic Uveal Melanoma Subgroups
September 16, 2024
From
Delcath Systems, Inc.
Via
Business Wire
Tickers
DCTH
Delcath Systems, Inc. Announces Positive Results from Independent Study on Liver-Directed Therapy for Uveal Melanoma Patients
August 28, 2024
From
Delcath Systems, Inc.
Via
Business Wire
Tickers
DCTH
Delcath Systems to Participate at the H.C. Wainwright 26th Annual Global Investment Conference
August 28, 2024
From
Delcath Systems, Inc.
Via
Business Wire
Tickers
DCTH
Delcath Systems, Inc. Announces Positive Outcomes from Independent Study on Hepatic Perfusion for Uveal Melanoma Patients
August 27, 2024
From
Delcath Systems, Inc.
Via
Business Wire
Tickers
DCTH
Delcath Systems, Inc. Announces Promising Results from Independent Study on Repeated Hepatic Chemosaturation for Liver Tumors
August 26, 2024
From
Delcath Systems, Inc.
Via
Business Wire
Tickers
DCTH
Delcath Systems Announces Poster Presentation at the 2024 ESMO Congress
August 20, 2024
From
Delcath Systems, Inc.
Via
Business Wire
Tickers
DCTH
Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 12, 2024
From
Delcath Systems, Inc.
Via
Business Wire
Tickers
DCTH
Delcath Systems Reports Second Quarter 2024 Results and Business Highlights
August 05, 2024
From
Delcath Systems, Inc.
Via
Business Wire
Tickers
DCTH
Delcath Systems Announces CMS Approval for NTAP for HEPZATO KIT™
August 05, 2024
From
Delcath Systems, Inc.
Via
Business Wire
Tickers
DCTH
Delcath Systems to Participate in Upcoming Investor Conferences
July 30, 2024
From
Delcath Systems, Inc.
Via
Business Wire
Tickers
DCTH
Delcath Systems to Host Second Quarter 2024 Earnings Call
July 22, 2024
From
Delcath Systems, Inc.
Via
Business Wire
Tickers
DCTH
Delcath Systems Announces Appointment of Bridget Martell, MA, MD to Delcath’s Board of Directors
May 28, 2024
From
Delcath Systems, Inc.
Via
Business Wire
Tickers
DCTH
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.